Dr Reddy's Laboratories's quarterly market cap
increased
from Jun. 2023 (R$45,505 Mil) to Sep. 2023 (R$55,600 Mil) but then
declined
from Sep. 2023 (R$55,600 Mil) to Dec. 2023 (R$53,800 Mil).
Dr Reddy's Laboratories's annual market cap
declined
from Mar. 2021 (R$57,673 Mil) to Mar. 2022 (R$50,883 Mil) and
declined
from Mar. 2022 (R$50,883 Mil) to Mar. 2023 (R$45,490 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dr Reddy's Laboratories's Enterprise Value for Today is R$59,332 Mil.
Dr Reddy's Laboratories Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr Reddy's Laboratories's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Reddy's Laboratories's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where Dr Reddy's Laboratories's Market Cap falls into.
Dr Reddy's Laboratories Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Dr Reddy's Laboratories's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Reddy's Laboratories (BSP:R1DY34) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Dr Reddy's Laboratories Market Cap Related Terms
Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr Reddy's Laboratories (BSP:R1DY34) Business Description
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:R1DY34 has been successfully added to your 